Aspen Aerogels (ASPN) Q3 Revenue Rose 71% QoQ to $85.2M

Aspen Aerogels reported Q3 revenue of $85.2M, up 71% YoY, with adjusted EBITDA of $19.8M and a net loss of $10.4M, including incident-related costs. The company cited sustained demand and facility recovery as key factors for future growth.

Original reporting
Published Nov 5, 2026, 11:30 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 11:38 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Aspen Aerogels (ASPN) Q3 Revenue Rose 71% QoQ to $85.2M — source image
Decision brief

The 30-second read

$ASPNBullishMed
01

Why it matters

The earnings beat may prompt short‑term buying pressure, yet the elevated loss and ongoing incident costs could limit upside and introduce volatility.

02

Market read

First‑time earnings release for ASPN with material revenue growth; relevant for specialty‑materials investors.

03

What to watch

Future Q4 guidance and the timeline for returning the East Providence facility to full capacity could materially affect performance.

Relevance 7/10Novelty 7/10Timing: after‑hours release

Background

Aspen Aerogels disclosed its Q3 2026 financial results, showing a sharp revenue increase but also higher net loss due to a recent incident at its East Providence plant.

Company-level read

Ticker impact

$ASPNBullishHigh confidence
Context

Q3 revenue rose 71% QoQ to $85.2M and adjusted EBITDA jumped to $19.8M, while net loss widened due to incident costs.

Expected impact

modest upside as investors price in higher revenue and profitability, tempered by loss and incident expenses

Evidence & confidence

Revenue beat and EBITDA expansion are positive catalysts; however, the widened net loss and ongoing incident costs create downside risk.

Market effects

Highlights recovery potential in advanced insulation materials and could lift peer specialty‑chemical stocks.

Limited to U.S. specialty‑materials sector; no broad regional effect.

Minimal global impact; primarily relevant to investors tracking niche industrials.

Counterpoint

The incident‑related costs and asset‑disposal loss may signal deeper operational issues, suggesting caution despite revenue growth.

Key entities

  • Aspen Aerogels, Inc.

    Manufacturer of aerogel insulation products.

Related articles

$ASPNMed

Aspen Aerogels Q3 Earnings Call Highlights

Aspen Aerogels reported Q3 revenue of $45.3M, up 54% sequentially, driven by GM and European automakers. Gross margin improved to 24% (41% ex-incident costs). The company forecasts Q4 revenue of $60M-$75M and full-year revenue of $233M-$248M. Aspen expects growth in battery energy storage and data center markets.

$ASPNMed

Aspen Aerogels Inc (ASPN) Q3 2026 Earnings Call Highlights: Revenue and Adjusted EBITDA

Aspen Aerogels (ASPN) reported Q3 2026 revenue of $85.2M and adjusted EBITDA of $19.8M, but incurred $15.1M in incident-related costs. Q4 revenue guidance is $60-75M. The company expects East Providence facility restoration to complete by H1 2027. CEO Donald Young discussed growth opportunities in data centers, LNG, and battery energy storage, but no plans for European fabrication.

$ASPNMed

Aspen Aerogels Q2 Earnings Call Highlights

Aspen Aerogels (ASPN) reported Q2 gross profit of $3.3M (7% margin) after $5.3M of incremental costs tied to an April explosion at its East Providence plant. Adjusted gross profit was $8.6M (17%). GAAP net loss was $23.3M. The company is restarting the plant and expects full capacity in 1H 2027, while raising 2026 European Thermal Barrier revenue outlook to $20M-$30M.

$ASPNMed

Beerenberg Prevails in Patent Case Against Aspen Aerogels

South Korea’s Patent Court invalidated three Aspen Aerogels patents covering improved hydrophobic aerogel material, according to the company’s press release. The ruling upheld the Intellectual Property Trial and Appeal Board’s view that the patents failed patentability requirements. Beerenberg, an insulation-products firm, said the decision removes uncertainty over infringement claims.